DK0506792T3 - Insulinpræparat, der indeholder nikotinsyre eller nikotinamid - Google Patents

Insulinpræparat, der indeholder nikotinsyre eller nikotinamid

Info

Publication number
DK0506792T3
DK0506792T3 DK91901711.1T DK91901711T DK0506792T3 DK 0506792 T3 DK0506792 T3 DK 0506792T3 DK 91901711 T DK91901711 T DK 91901711T DK 0506792 T3 DK0506792 T3 DK 0506792T3
Authority
DK
Denmark
Prior art keywords
nicotinic acid
nicotinamide
pct
preparation containing
insulin preparation
Prior art date
Application number
DK91901711.1T
Other languages
Danish (da)
English (en)
Inventor
Klavs Holger Jorgensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK654389A external-priority patent/DK654389D0/da
Priority claimed from DK7190A external-priority patent/DK7190D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0506792T3 publication Critical patent/DK0506792T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK91901711.1T 1989-12-21 1990-12-20 Insulinpræparat, der indeholder nikotinsyre eller nikotinamid DK0506792T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK654389A DK654389D0 (da) 1989-12-21 1989-12-21 Laegemiddel
DK7190A DK7190D0 (da) 1990-01-10 1990-01-10 Laegemiddel

Publications (1)

Publication Number Publication Date
DK0506792T3 true DK0506792T3 (da) 1995-10-09

Family

ID=26063239

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91901711.1T DK0506792T3 (da) 1989-12-21 1990-12-20 Insulinpræparat, der indeholder nikotinsyre eller nikotinamid

Country Status (10)

Country Link
US (1) US5382574A (fr)
EP (1) EP0506792B1 (fr)
JP (1) JP3122128B2 (fr)
AT (1) ATE122567T1 (fr)
AU (1) AU641721B2 (fr)
CA (1) CA2070814A1 (fr)
DE (1) DE69019534T2 (fr)
DK (1) DK0506792T3 (fr)
ES (1) ES2072596T3 (fr)
WO (1) WO1991009617A1 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3562195A (en) * 1994-10-04 1996-04-26 Novo Nordisk A/S Preparations containing aspb28 human insulin and nicotinamide
US5830999A (en) * 1995-01-26 1998-11-03 Regents Of The University Of California Stabilization of insulin through ligand binding interations
EP0880969A1 (fr) 1997-05-28 1998-12-02 Applied Research Systems ARS Holdings N.V. Compositions pharmaceutiques de peptides de faible solubilité dans un milieu physioloqique
BR9913857A (pt) * 1998-09-17 2001-06-12 Lilly Co Eli Formulações de proteìna
US6573237B2 (en) 2001-03-16 2003-06-03 Eli Lilly And Company Protein formulations
EP2107069B1 (fr) 2003-08-05 2013-01-16 Novo Nordisk A/S Nouveaux dérivés d'insuline
EP1755579A4 (fr) * 2004-05-24 2009-06-10 Univ New York Methode de traitement ou de prevention d'effets pathologiques d'augmentations aigues de l'hyperglycemie et/ou d'augmentations aigues de flux d'acides gras libres
US9737511B2 (en) * 2004-05-24 2017-08-22 Geoffrey C. GURTNER Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
PT1969004E (pt) * 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
JP5552046B2 (ja) * 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー／エス インスリン誘導体を含有する薬学的製剤
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
EP2352513B1 (fr) 2008-10-30 2016-09-14 Novo Nordisk A/S Traitement du diabète à l'aide d'injections d'insuline avec une fréquence inférieure à une injection par jour
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
DK2340033T3 (da) * 2009-06-26 2014-01-20 Novo Nordisk As Præparat, der omfatter insulin, nicotinamid og arginin
AU2013203134B2 (en) * 2009-06-26 2016-05-12 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
JP2013545782A (ja) 2010-12-14 2013-12-26 ノヴォ ノルディスク アー／エス 長時間作用型インスリンと組み合わせた速効型インスリン
WO2012080362A1 (fr) 2010-12-14 2012-06-21 Novo Nordisk A/S Préparation comportant de l'insuline, du nicotinamide et un acide aminé
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
WO2013130935A1 (fr) * 2012-03-02 2013-09-06 Genentech, Inc. Dérivés sulfoxydes amido-benzyliques
WO2013130943A1 (fr) * 2012-03-02 2013-09-06 Genentech, Inc. Dérivés sulfonamides amido-benzyliques substitués par un groupe alkyle et disubstitués
EP2873422A4 (fr) * 2012-07-10 2015-12-30 Takeda Pharmaceutical Préparation pharmaceutique pour l'injection
JP6322642B2 (ja) 2012-11-13 2018-05-09 アドシア 置換されたアニオン性化合物を含有する速効型インスリン製剤
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
WO2015120457A1 (fr) * 2014-02-10 2015-08-13 Biodel Inc. Formulations d'insuline à action ultrarapide stabilisées
AR099569A1 (es) * 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
EP3113791B1 (fr) * 2014-03-07 2018-12-26 Jørgensen, Klavs Holger Nouvelles préparations d'insuline à action rapide
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
US11352406B2 (en) * 2015-08-25 2022-06-07 Novo Nordisk A/S Insulin derivatives and the medical uses hereof
US20190010206A1 (en) * 2015-08-25 2019-01-10 Novo Nordisk A/S Novel Insulin Derivatives and the Medical Uses Hereof
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
CA3034972C (fr) 2016-09-29 2024-04-09 Arecor Limited Formulation d'insuline pharmaceutique
US20190352374A1 (en) 2017-01-30 2019-11-21 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Novel igfr_like 2 receptor and uses thereof
GB201707188D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707187D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707189D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
WO2019055490A1 (fr) 2017-09-14 2019-03-21 The Board Of Trustees Of The Leland Stanford Junior University Conditionnement de tissu irradié pour rétention de greffe de graisse
US20210113763A1 (en) 2018-04-04 2021-04-22 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
US20210038506A1 (en) 2018-04-04 2021-02-11 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
CA3094304A1 (fr) 2018-04-04 2019-10-10 Arecor Limited Systeme de pompe a perfusion medicale pour l'administration d'un compose d'insuline
TWI829687B (zh) * 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
FR3083984A1 (fr) 2018-07-23 2020-01-24 Adocia Dispositif pour injecter une solution d'insuline(s)
WO2019243627A1 (fr) 2018-06-23 2019-12-26 Adocia Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr) 2018-07-23 2020-01-24 Adocia Dispositif pour injecter une solution d'insuline(s)
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
AR120717A1 (es) 2019-12-11 2022-03-09 Novo Nordisk As Análogos de insulina y usos de los mismos
GB202004814D0 (en) 2020-04-01 2020-05-13 Arecor Ltd Novel formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2793977A (en) * 1951-08-31 1957-05-28 Caspe Saul Compositions and method for reducing blood sugar concentration
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1603639A (en) * 1978-05-26 1981-11-25 Haggar H Composition for application to the hair and scalp
US5155096A (en) * 1987-06-15 1992-10-13 Garcia Y Bellon Donato P Method for potentiation of a therapeutic agent
CA1299102C (fr) * 1987-06-15 1992-04-21 Steven G. Ayre Therapie de potentialisation a l'insuline
AU2523588A (en) * 1987-10-08 1989-05-02 Andor Bilas Mixture of substances for stabilyzing metabolism

Also Published As

Publication number Publication date
JP3122128B2 (ja) 2001-01-09
ES2072596T3 (es) 1995-07-16
AU7047191A (en) 1991-07-24
US5382574A (en) 1995-01-17
EP0506792B1 (fr) 1995-05-17
EP0506792A1 (fr) 1992-10-07
DE69019534T2 (de) 1995-09-21
ATE122567T1 (de) 1995-06-15
JPH05502234A (ja) 1993-04-22
DE69019534D1 (de) 1995-06-22
WO1991009617A1 (fr) 1991-07-11
AU641721B2 (en) 1993-09-30
CA2070814A1 (fr) 1991-06-22

Similar Documents

Publication Publication Date Title
DK0506792T3 (da) Insulinpræparat, der indeholder nikotinsyre eller nikotinamid
TR27525A (tr) Propenoik asit türevleri, hazirlanmalarina mahsus usuller ve fungisid olarak kullanimlari.
DE3677316D1 (de) 4(4-oxo-1,4-dihydropyridin-1-yl)phenyl-derivate.
NO904584L (no) Preparater inneholdende hyaluronsyreforbindelser samt fremgangsmaate for fremstilling derav.
FI860473A0 (fi) Nya -(2-okso-2,4,5,6,7,7a -hexahydro-tieno(3,2-c)-5-pyridyl)fenylaettiksyraderivat, foerfarande foer deras framstaellning och deras terapeutiska anvaendning.
DK0473333T3 (da) Modificeret polydextrose og fremgangsmåde til fremstilling heraf
NO880558L (no) Pyridin-2,4- og 2,5-dikarboksylsyreamid, samt fremgangsmaate for fremstilling derav.
NO875358D0 (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO870512L (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
DE69225410T2 (de) Herstellung von n-acetylneuraminsäure-derivaten
FI894027A0 (fi) Rotator foer kranburna arbetsredskap, i synnerhet traedbearbetningsaggregat.
IT1205115B (it) Metodo per preparare poliammidi aromatiche e polibenzossazoli
ATE64526T1 (de) Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion.
DK62288A (da) Substituerede 2,6-substituerede pyridinforbindelser og herbicide praeparater indeholdende disse forbindelser
DE3877802D1 (de) Phenoxypropionsaeure-derivate, anwendbar als herbizide.
DK0482108T3 (da) Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf
ES2009828B3 (es) Nuevo derivado benzaldehido, su preparacion y su aplicacion
NO870834L (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
AU7299987A (en) Fungicidal compositions based on nicotinic acid derivatives, new nicotinic acid derivatives and preparation thereof
DK191290D0 (da) Extracellulaer exopolymer, fremgangsmaade til fremstilling af samme og farmaceutiske praeparater indeholdende exopolymeren
ES8500057A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.
AU577216B1 (en) 2,6-bis(aminophenoxy) pyridine
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.
MY104782A (en) Glutaric acid derivatives and preparations thereof.
DK0463139T3 (da) 2,13-disubstituerede ergoliner, deres fremstilling og deres anvendelse i lægemidler